Suppr超能文献

术前放疗及膀胱切除术后膀胱癌DNA倍体的预测价值

Predictive value of DNA ploidy in bladder cancer treated with preoperative radiation therapy and cystectomy.

作者信息

Granfors T, Duchek M, Tomic R, Roos G, Ljungberg B

机构信息

Department of Urology & Andrology, Umeå University, Sweden.

出版信息

Scand J Urol Nephrol. 1996 Aug;30(4):281-5. doi: 10.3109/00365599609182307.

Abstract

The predictive value of flow cytometric DNA analysis of cells from bladder washings was evaluated in 43 patients with muscle-invasive or recurrent superficial bladder cancer treated with preoperative radiotherapy and cystectomy. There was no correlation between ploidy status of the primary tumour and survival, neither was there any correlation between ploidy and the occurrence of residual tumour in the cystectomy specimens. Patients without residual tumours in the cystectomy specimen had significantly longer survival time than those with residual tumours. Concomitant carcinoma in situ was correlated with better survival, which is surprising, considering the malignant potential of this lesion. In this study DNA ploidy did not predict tumour response to radiotherapy nor was it of any prognostic significance.

摘要

对43例接受术前放疗和膀胱切除术治疗的肌层浸润性或复发性浅表性膀胱癌患者,评估了膀胱冲洗液细胞的流式细胞术DNA分析的预测价值。原发肿瘤的倍体状态与生存率之间无相关性,倍体与膀胱切除标本中残留肿瘤的发生也无相关性。膀胱切除标本中无残留肿瘤的患者生存时间明显长于有残留肿瘤的患者。同时存在的原位癌与较好的生存率相关,考虑到该病变的恶性潜能,这一点令人惊讶。在本研究中,DNA倍体不能预测肿瘤对放疗的反应,也没有任何预后意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验